ALBIREO PHARMA, INC. Quarterly Cost of Revenue in USD from Q3 2021 to Q3 2022

Taxonomy & unit
us-gaap: USD
Description
The aggregate cost of goods produced and sold and services rendered during the reporting period.
Summary
Albireo Pharma, Inc. quarterly/annual Cost of Revenue history and growth rate from Q3 2021 to Q3 2022.
  • Albireo Pharma, Inc. Cost of Revenue for the quarter ending September 30, 2022 was $612K, a 42% increase year-over-year.
Cost of Revenue, Quarterly (USD)
Cost of Revenue, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q3 2022 $612K +$181K +42% Jul 1, 2022 Sep 30, 2022 10-Q 2022-11-08
Q2 2022 $776K Apr 1, 2022 Jun 30, 2022 10-Q 2022-08-15
Q1 2022 $234K Jan 1, 2022 Mar 31, 2022 10-Q 2022-05-16
Q3 2021 $431K Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-08
* An asterisk sign (*) next to the value indicates that the value is likely invalid.